论文部分内容阅读
目的:分析在肺癌患者肺部感染的治疗过程中,应用抗菌药物联合痰热清注射液进行治疗的效果。方法:将2015年5月~2016年5月我院接收的肺癌肺部感染患者80例随机分为研究组和对照组,每组40例,并对研究组采用敏感抗菌药物联合痰热清注射液治疗的措施,对对照组采用替考拉宁药物治疗措施,并将两组最终的治疗时长、住院时长、治疗成本和治疗效果进行比较。结果:研究组的治疗和住院周期短于对照组,治疗成本低于对照组;研究组的患者止咳经过(6.25±1.25)天,退热经过(1.88±1.19)天,而对照组分别为(9.12±2.48)天及(2.94±2.25)天,研究者用时较对照组少;研究组治疗整体有效百分比为85.00%,而对照组为57.50%,明显比研究组低。以上比较结果均存在统计学差异(P<0.05)。结论:在治疗肺癌患者肺部感染的过程中,采用敏感抗菌药物联合痰热清注射液治疗的措施具有良好成效。
Objective: To analyze the effect of antibacterial therapy and Tanreqing injection in the treatment of pulmonary infection in patients with lung cancer. Methods: From May 2015 to May 2016, 80 patients with pulmonary lung infection received in our hospital were randomly divided into study group and control group, with 40 cases in each group. The patients in study group were treated with sensitive antibacterial drugs combined with Tanreqing Injection Liquid treatment measures for the control group teicoplanin drug treatment measures, and the two groups of the final treatment time, duration of hospitalization, treatment costs and treatment were compared. Results: The study group’s treatment and hospitalization period were shorter than the control group, and the treatment cost was lower than that of the control group. In the study group, the cough was (6.25 ± 1.25) days and the fever was (1.88 ± 1.19) days while the control group was 9.12 ± 2.48) days and (2.94 ± 2.25) days, the researchers spent less time than the control group; the study group, the overall effective percentage was 85.00%, while the control group was 57.50%, significantly lower than the study group. The above results are statistically significant (P <0.05). Conclusion: In the treatment of pulmonary infection in patients with lung cancer, the use of sensitive antibiotics combined with Tanreqing injection treatment has good results.